Bioanalysis discontinued subject [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2018-08-02 11:14 (991 d 00:39 ago) – Posting: # 19127
Views: 2,204

Hi Johanne,

first of all, from a data perspective I agree with what Helmut said.

However, I recall a case where the authority interpretation of a withdrawn consent was that if a trial subject withdraws her consent, then it implicitly also implies that she withdraws her permission for the CRO to touch the un-analysed samples she has given up until the time of consent retraction. This is of course a matter of interpretation, but actually it also makes sense to me.
When it comes to rights of trial subjects there is no reason to take any chances. In this regard we need to think about ICH E6 §2.3 - rights, safety and well-being before science. Other clauses are in play, too.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 20 (0 registered, 20 guests [including 3 identified bots]).
Forum time: Monday 11:54 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5